NeuralFrame LLC, a medical technology company that uses artificial intelligence (AI) to convert unstructured medical text into structured data, aligns with leading technology associations and organizations to offer a best-in-class software solution for cancer tumor registries.
A member of NVIDIA’s Inception program, NeuralFrame is on the forefront of advances in AI. NVIDIA’s program is designed to nurture startups, revolutionizing industries with advancement in AI and data science. Through the Inception program, NeuralFrame stays on the cutting-edge of AI by accessing NVIDIA’s global ecosystem—a massive network of deep learning experts and thought leaders.
NeuralFrame also holds a gold membership with HL7® (Health Level 7 International). For over 30 years, HL7 has been dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing, and retrieval of electronic health information. Through the relationship with HL7, NeuralFrame is helping to make interoperability a reality; its products and services are being developed using the world’s most-widely adopted healthcare standards.